Michael Makris: Lower Bleeding Risk With Apixaban vs Rivaroxaban in Acute Venous Thrombosis
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared a post on LinkedIn about a recent article by Lana Castellucci et al, adding:
“Important paper for clinical practice.
A large study, independent of the pharma industry, found that in the setting of acute venous thrombosis, the risk of clinically relevant bleeding was:
- 3.3 percent with Apixaban
- 7.3 percent with Rivaroxaban
This difference was significant.
Congratulations to Lana Castellucci for coordinating this multicentre study.
We await the results of their AF study with interest.
Considering how many patients worldwide are on these drugs, this will be an impactful study.
The attached figure gives the summary.
The original article in this week’s New England Journal of Medicine is behind a paywall.”
Title: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
Authors: Lana A. Castellucci, Vivien M. Chen, Michael J. Kovacs, Alejandro Lazo-Langner, Peter Greenstreet, Susan Kahn, Benoit Côté, Sam Schulman, Kerstin de Wit, James Douketis, Deepa Suryanarayan, Tony Wan, Erik Yeo, Genevieve Le Templier, Huyen A. Tran, Abbey Willcox, Helen J. Crowther, Ritam Prasad, Sudeep Shivakumar, Etimbuk Umana, Fionnuala Ni Ainle, Tobias Tritschler, Stefano Barco, Jean-Philippe Galanaud, Marc Blondon, Lisa Baumann Kreuziger, Susan Solymoss, Clive Kearon, Erin Thomas, Tim Ramsay, Gregoire Le Gal, Marc Rodger
Read the Full Article on The New England Journal of Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 14:10Mary Akua Ampomah: Academic Institutions Stand in Solidarity to End Stigma on World Inherited Blood Disorders Day
-
Oct 31, 2026, 14:01Konstantina Bolou: Investigating the Diagnostic Accuracy of Ultrasound Compared to MRI for Haemophilic Arthopathy
-
Oct 31, 2026, 13:40Mona Alfaraj: Speaking on Inherited Macrothrombocytopenia Diagnostics at the 2026 EHC Conference in Dammam
-
Oct 31, 2026, 13:36Sumaiya Thasnim: How Hemolysis, Lipemia and Icterus Affect Immunoassays
-
Oct 31, 2026, 13:30Tammuella Chrisentery-Singleton: ATHN Brings Science and Celebration to New Orleans
-
Oct 31, 2026, 12:21Niksa Bagheri: Key Shear Regimes and Physics Selection for Continuum Thrombosis Modeling
-
Oct 31, 2026, 12:14Ghaith Abu-Zeinah: International MPN Congress Honors the Life and Legacy of MPN Pioneer Dr. Richard T. Silver
-
Oct 31, 2026, 12:11Thierry Burnouf: Taipei Medical University and University of Lille Highlight Platelet Biotherapies in SfN Neuronline
-
Oct 31, 2026, 12:07Eamon Faulkner: How Oxygen Shapes Platelet–Endothelial Interactions